Organon

Organon is a global healthcare company specializing in women's health pharmaceuticals, biosimilars, and established prescription medicines. Headquartered in Jersey City, New Jersey, the company develops and supplies prescription drugs across more than 140 international markets including North America, Europe, Asia-Pacific, and Latin America. Its healthcare portfolio includes over 70 branded therapies targeting reproductive health, contraception, fertility, cardiovascular diseases, dermatology, autoimmune conditions, and respiratory disorders. Key commercial drug products offered include Nexplanon etonogestrel subdermal implants, NuvaRing vaginal rings, Follistim AQ injections, Hadlima biosimilars, Dulera inhalation aerosols, and Singulair tablets. In addition to female reproductive therapies, the biopharmaceutical manufacturer produces treatments for central nervous system disorders, bone health, and hypercholesterolemia. The company provides dedicated patient support programs, medical safety reporting, and prescription assistance resources to support patients and healthcare providers. Organon operates regional distribution offices and manufacturing facilities in major global hubs such as London, Munich, Tokyo, Sao Paulo, and Shanghai. Healthcare organizations, pharmacies, and patients access these therapeutic solutions through authorized global distribution channels and specialized medical service networks.